Delaet Ingrid sold NBIX
July 10, 2026 · Form 4 insider transaction
Delaet Ingrid sold 4,367 shares of Neurocrine Biosciences, Inc. at $181.02 per share, a transaction worth $790.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,367
Price
$181.02
Total value
$790.5K
InsiderDelaet Ingrid
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 10, 2026
Filing dateJuly 13, 2026
Shares owned after16,225
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.